Categories
Health

Pharmacy workers from Walgreens, chains like CVS to stroll out once more

A sign advertises COVID-19 (coronavirus) vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, August 14, 2023.

Brian Snyder | Reuters

Some pharmacy staff from Walgreens and other drugstore chains are planning to walk out next week in the latest pushback against what they call unsafe working conditions that put both employees and patients at risk. 

Organizers of the effort and some pharmacy employees told CNBC they hope the work stoppage will push companies to make meaningful changes to address the long-standing grievances of many retail pharmacy staff, who have complained about having to grapple with what they describe as understaffed teams, insufficient pay and increasing work expectations imposed by corporate management. 

The walkout, which organizers have dubbed “Pharmageddon,” will occur Monday through Wednesday across different retail pharmacy locations nationwide, organizers of the effort told CNBC. 

An organizer named Shane Jerominski, an independent pharmacist who used to work for Walgreens, said the walkout could tentatively affect hundreds of stores across different chains.

Jerominski, who is a pharmacy labor advocate, said organizers still don’t have a definitive count of employees who will participate in the effort. But he noted that the “bulk” of those who have signaled they plan to walk out are staff from Walgreens — who laid the groundwork for the initiative — and employees from CVS and Rite Aid.

Organizers are also planning to hold rallies outside a few locations in different parts of the country, according to Jerominski and a second person involved with the planning, who requested to remain anonymous for fear of retaliation.

Jerominski and the person, who is a former pharmacy manager at supermarket chain Publix, also said they are considering a push for unionization of pharmacy staff who are currently not represented. There are no concrete agreements to move forward to join a labor group. 

A spokesperson for Walgreens said the company recognizes the “incredible work our pharmacists and technicians do every day” and that it has taken several steps in its pharmacies “to ensure that our teams can concentrate on providing optimal patient care.” 

The company’s ongoing efforts are focused on how it can recruit, retain and reward pharmacy staff, the spokesperson said. They added that Walgreens has improved technology and centralized many operations to help maintain appropriate workloads in pharmacies. 

A CVS spokesperson said in a statement that the company isn’t seeing any “unusual activity regarding unplanned pharmacy closures or pharmacist walkouts currently.” 

The spokesperson added that the company is engaging with staff to directly address any concerns they might have, and is focused on developing a “sustainable, scalable action plan” to support both pharmacists and customers. 

A spokesperson for Rite Aid did not immediately respond to a request for comment on the upcoming walkout. 

The work stoppage will come weeks after some pharmacy staff from Walgreens locations around the country, and CVS stores in the Kansas City area, engaged in separate walkouts over working conditions. Notably, CVS management apologized to Kansas City pharmacy staff and committed to a series of improvements — including adding staff and paid overtime — after the walkouts there ended. 

The demonstrations at pharmacies add to what has been one of the most active years for the U.S. labor movement in recent history. 

CVS and Walgreens were the biggest pharmacies in the U.S. based on prescription drug market share in 2022. Both chains operate around 9,000 retail store locations across the country. 

CVS has more than 30,000 pharmacists and 70,000 pharmacy technicians, while rival Walgreens has more than 86,000 health-care service providers, including pharmacists, pharmacy technicians and other positions. CVS pharmacists make $61.44 an hour on average, while Walgreens pharmacists make $53.85 per hour on average, according to employment website Indeed.

Who is participating in the pharmacy walkouts? 

As pharmacy workers prepare to walk off the job, Jerominski and the former Publix pharmacy manager said some independent and retail pharmacy locations have committed to staying open next week to provide patients with service options.

Many of the pharmacy staff who are interested in walking out appear to be from Massachusetts, Pennsylvania, California, Texas, Michigan, Missouri and Indiana, according to Jerominski.

Two pharmacy staff members from Walgreens and another two from CVS, all of whom asked to remain anonymous for fear of retribution, told CNBC that they plan to walk out. One CVS store manager, who also asked to remain anonymous for the same reason, said they would participate if their location’s pharmacist does.

A CVS location in New York, US, on Thursday, Feb. 9, 2023.

Stephanie Keith | Bloomberg | Getty Images

Other employees don’t intend to walk out, even if they support the broader effort to secure better working conditions.

A CVS employee, who was the main organizer of the Kansas City area walkouts, said the CVS pharmacy staff in that region that they represent are not inclined to participate. The employee, who asked to remain anonymous for fear of retribution, said CVS has negotiated with Kansas City staff “in good faith and made good on commitments thus far,” so walking out again would be “going backwards.”

A CVS pharmacy manager, who works in a different part of the country, said they have seen positive changes at their own store following the Kansas City walkouts. 

But the pharmacy manager, who also requested anonymity for fear of retaliation, said they will participate in one day of the upcoming walkout — and hope their colleagues will too — because they believe employees need to replicate the solidarity seen in Kansas City “on a larger scale” to ensure CVS continues to listen to their concerns.

Why are pharmacy staff walking out?

For years, many retail pharmacy employees have complained that companies such as Walgreens and CVS are placing unreasonable performance demands on employees, without providing enough staffing or resources for them to safely and responsibly execute tasks. 

They believe the issue got worse during the Covid pandemic, when pharmacists and technicians were also required to administer back-to-back tests and vaccinations on top of their normal duties. 

Many pharmacy staff told CNBC that a diminishing number of workers have to juggle ever-increasing daily tasks, which they said can force errors and put patients at risk of serious harm. 

“It boils down to us not being as attentive as we need to be when it comes to making sure people get the right medicines or making sure patients are properly educated and assisted,” a CVS pharmacist said.

Roughly 100,000 prescription errors are voluntarily reported to the Food and Drug Administration annually. Between 7,000 and 9,000 people in the U.S. die every year due to medication errors.

Some employees said the working conditions also weigh on their mental and physical health. Many staffers described feeling burnt out by their workloads.

In addition to filling and verifying prescriptions, pharmacy employees often have to juggle patient phone calls, administer vaccines every 15 minutes, resolve issues with insurance companies and doctors, perform rapid Covid and flu tests and deal with in-store customers.

“We come home and you can’t even think of doing other things because you’re just so exhausted,” a Walgreens pharmacy technician told CNBC, likening their work shift to a marathon. “I’ve been falling asleep just sitting down.”

New vaccine COMIRNATY® (COVID-19 Vaccine, mRNA) by Pfizer, available at CVS Pharmacy in Eagle Rock, CA. 

Irfan Khan | Los Angeles Times | Getty Images

Some pharmacy staff told CNBC that company-imposed performance metrics, such as filling a specific number of prescriptions a day or administering a certain number of vaccines, add even more pressure on them. 

Jerominski, the organizer and pharmacy labor advocate, claimed immunizations have become a chief priority for retail pharmacy chains because the margins on vaccines are significantly higher than the average prescription.

The CVS spokesperson said the company has reduced the number of metrics it uses in recent years, but noted the information “gleaned from safety and quality metrics provides us with a clearer picture of what’s working and where improvements may be needed.” 

Meanwhile, Walgreens announced the elimination of performance-based metrics last year, making it the only drugstore chain to do so. 

However, some Walgreens pharmacy staff told CNBC that the company continues to push their stores to hit performance goals for tasks like verifying prescriptions. Walgreens has denied employee claims that those metrics still exist.  

The former Publix pharmacy manager claimed that those types of working conditions are why few people want to work for large retail drugstore chains.

What else are pharmacy staff hoping for?

Unionization is “one hugely important piece of this process,” no matter which existing labor union steps up to represent pharmacy employees who aren’t currently represented, Jerominski said. 

He noted the vast majority of pharmacists and technicians from Walgreens and CVS have no union representation, while pharmacy staff from a handful of grocery retailers such as Kroger do. 

Jerominski said he has organized a fundraiser for a national push to unionize, which had collected nearly $60,000 as of Friday. Organizers have been in talks with multiple existing unions over the past two months, but there is no concrete agreement yet to move forward, he added. 

Jerominski said the organizations include IAM Healthcare, a union representing thousands of professionals in the health-care industry, and the United Food and Commercial Workers International Union, which represents food, retail and health-care workers across the U.S. and Canada. 

IAM Healthcare did not immediately respond to a request for comment, while UFCW has expressed its support for the recent walkouts staged by Walgreens and CVS pharmacy staff.

People make their way near a Walgreens pharmacy in New York City, March 9, 2023.

Leonardo Munoz | Corbis News | Getty Images

Some pharmacy employees also told CNBC they hope the upcoming walkout will help patients better understand the conditions employees are working in and why they may lead to longer wait times, medication errors or similar issues.

One Walgreens pharmacist said they believe patients are understandably upset when they can’t pick up their medications in a quick and seamless way. However, it can be emotionally taxing for employees when they have to deal with patients who get aggressive or, in rare cases, violent, the pharmacist said. 

Similarly, the CVS store manager said they hope the walkout will make patients more understanding.

“At the very least, I hope this results in one customer that can come in and say, ‘Hey, I get it. I’ll be right here and I’ll be patient,'” the CVS store manager said. “If it changes one customer from coming in an immediately cussing and screaming at myself — even if it’s rightfully so — then it’s absolutely worth it.”

Categories
Technology

UN creates AI advisory physique to ‘maximise’ advantages for humankind

UN Secretary-General António Guterres has unveiled a dedicated AI advisory body with a mandate to harness the technology’s power for good and mitigate its risks through international collaboration and governance.

“AI could power extraordinary progress for humanity,” Guterres said, pointing to a plethora of benefits — from health and education to the digitalisation of developing economies. In addition, “it could supercharge climate action and efforts to achieve the [UN’s] 17 Sustainable Development Goals by 2030,” he added.

However, Guterres cautioned that AI expertise is currently “concentrated in a handful of companies and countries.” This could heighten global inequalities, increase the spread of disinformation and bias, enable surveillance and invasion of privacy — and, overall, lead to the violation of human rights.

“Without entering into a host of doomsday scenarios, it is already clear that the malicious use of AI could undermine trust in institutions, weaken social cohesion, and threaten democracy itself,” noted the Secretary General. “For all these reasons, I have called for a global, multidisciplinary, multistakeholder conversation on the governance of AI so that its benefits to humanity — all of humanity — are maximised, and the risks contained are diminished.”

Take part in the Financial Times & TNW Health Technology Summit on 30 November.

Join leaders from NHS England, Bayer Cosumer Health, LSE, Cancer Research UK and more online.

By the end of this year, UN’s AI advisory body will make preliminary recommendations for three specific areas. These cover international governance of artificial intelligence; a shared understanding of risks and challenges; and key opportunities and enablers for the organisation’s Sustainable Development Goals.

These recommendations will be used for the preparation of the UN’s Summit for the Future in 2024, and will specifically form part of the proposed Global Digital Compact. The initiative aims to outline shared principles for “an open, free, and secure digital future” for all humanity.

The 39-member body hails from a wide range of countries and sectors, such as private companies, academia, governments, and civil society organisations.

Similar global initiatives to ensure the responsible use of artificial intelligence include the G7 AI code of conduct and the upcoming AI Safety Summit in London.

Categories
Science

Future Eventualities Border On Adventurous Hypothesis • Watts Up With That?

From the NoTricksZone

By P Gosselin

By Fritz Vahrenholt und Frank Bosse

A look back at an article about the imminent “tipping point” of the Atlantic overturning circulation:

At the end of July 2023 we had reported on an essay that thought to have identified the “tipping point” of the Atlantic overturning circulation (AMOC): Supposedly (most likely) it will be already in 2057. The author stirred up a lot of dust, we described it. Our summary at the time:

DD23 is a statistical exercise, very remote from any evidence of physical significance to AMOC itself. The conclusions therein are not supported by the content of the paper.”

In the meantime (mid-September 2023), another unreviewed (preprint) paper appeared and finds very similar things. It uses several sea surface temperature (SST) data series and another AMOC “fingerprint,” a dipole that avoids including warming itself in the result of the AMOC decrease it is looking for.

And lo and behold, it comes to quite different conclusions. Depending on which series one uses – especially in the early years up to about 1950, they are very patchy in direct observation and what is missing is filled in by various “infill methods” which have a strong impact on the statistics as they underlie the paper in question – one comes to completely divergent results. For example, the AMOC “collapse” is delayed by nearly a hundred years if one uses the same “fingerprint”, only a different SST series (Instead of HadISST1 ERSSTv5).

The other “fingerprint”, also based on SST, pushes the “collapse” determined by the methods in the paper to between 2100 to the year 3300 and beyond! At the end, the authors, who interestingly include Niklas Boers of the Potsdam Institute (PIK), who is probably concerned about the scientific reputation of the institution, write:

We emphasize that these uncertainties, originating from underlying modelling or mechanistic assumptions as well as from the employed empirical data, need to be taken into account and propagated thoroughly before attempting to estimate a future tipping time of any potential Earth system tipping element.”

ANY estimate of the timing of a “tipping point” must take the uncertainties into account, which are so substantial that they are all unsound when made.

Bet you won’t read that in the media? They had their hands full, with the active assistance of Prof. Rahmstorf, also from the PIK, to propagate the near end of the AMOC.

For this, attentive readers has this blog.

Like this:

Like Loading…

Categories
Entertainment

Paris Hilton and Jessica Alba Gown Up as Britney Spears for Halloween

Paris Hilton and Jessica Alba will intoxicate you with their Halloween costumes.

On Oct. 27, the Paris in Love star and Honest Company co-founder arrived separately at the annual star-studded Casamigos Halloween party with each wearing one of the styles that Britney Spears sports in her iconic 2003 music video “Toxic.”

Paris, a longtime friend of the pop star, sported a teal flight attendant costume. She attended the party with her husband Carter Reum, who was dressed up as a pilot. She also posted on Instagram a video of herself walking and modeling her outfit to the tune of the intro to Britney’s 2007 music video “Gimme More.” Paris lip-syncs, “It’s Britney, bitch.”

“In honor of our Queen,” the heiress captioned her post. “Happy Halloween. #IconsOnly.”

Jessica wore a sparkling nude bodysuit to the Casamigos party. The Sin City actress was accompanied by Baby2Baby co-CEO Kelly Sawyer Patricof, who arrived in a schoolgirl costume that Britney wears in her 1998 debut music video “…Baby One More Time.”

Categories
Sport

Clasico 2023: Barcelona vs. Actual Madrid predictions, picks

Oct 26, 2023, 08:19 AM ETBarcelona host Real Madrid on Saturday in the first Clasico of the 2023-24 LaLiga season. Who will win and get an early edge in the title race? Illustration by ESPN

Saturday is a special day in LaLiga as we get our first Clasico of the 2023-24 season as Barcelona host eternal rivals Real Madrid. These games are always big events — this is their 255th official meeting, with Real Madrid edging the series with 102 wins to Barca’s 100 and 52 draws — and it’s very much true heading into their clash at Montjuic.

Even though the game will take place at Olympic Stadium due to renovations at Barça’s Camp Nou home, the atmosphere will be every bit as electric. The home side will need that in order to prevail. Not only are Carlo Ancelotti’s Real side top of the table after 10 games, with Barça just a point behind them, but Los Blancos have been dominant in recent meetings, beating Barcelona 4-0 in the Copa del Rey semifinal, second leg and winning three of their last four away games against Xavi’s side.

– Stream LIVE: Barcelona vs. Real Madrid, 10 a.m. ET, ESPN+ (U.S.)
– Stream on ESPN+: LaLiga, Bundesliga & more (U.S.)

That said, Barça are reigning LaLiga champions and will be hoping to rebalance the rivalry this weekend. So how will the two teams fare on Saturday? What kind of form is each team in? Are there good bets to make? Who will be the key players that impact the final result? And who do our experts think will win?

What’s new since the last Clasico, and how have these teams progressed since

The spoils were shared last season, but Barça will feel they edged it by beating Madrid in the Spanish Super Cup final and again at Camp Nou on their way to the 2022-23 LaLiga title. Madrid, who had won last season’s league meeting at the Santiago Bernabeu, responded with a thumping 4-1 aggregate win in the semifinal of the Copa del Rey. However, there have been changes on both sides of the divide since.

play

0:59

Xavi: Barcelona will be at 100% for El Clasico

Barcelona boss Xavi says his side are in good shape for Saturday’s clash with Real Madrid after their 2-1 win vs. Shakhtar Donetsk in the Champions League.

Madrid’s talisman Karim Benzema left for the Saudi Pro League, so Carlo Ancelotti has re-built around Vinicius Jr. and €100 million signing Jude Bellingham, who has made a scintillating start to his career at the club. Elsewhere, Ancelotti is starting to phase out veteran midfielder Luka Modric, while Fran García, Joselu and Kepa Arrizabalaga also arrived in the summer. The latter replaced goalkeeper Thibaut Courtois who, like Eder Milito, is sidelined with a long-term ACL injury.

Meanwhile, Barça are trying to evolve under Xavi Hernandez. A solid backline won them LaLiga this season, but Xavi wants to improve the attack. João Cancelo, João Félix and Ilkay Gündogan all joined this summer in order to help with that objective; veteran midfielder Oriol Romeu and defender Iñigo Martínez also signed in the summer as Sergio Busquets, Jordi Alba and Ousmane Dembélé (among others) departed. An unbeaten start to the season has followed, albeit with ups and downs along the way, and they go into Saturday’s game just a point behind LaLiga leaders Madrid. — Sam Marsden

How have Barca and Real Madrid looked so far this season?

Real Madrid go into this Clasico at the top of the table, with eight wins, a draw — Saturday’s 1-1 at Sevilla — and just one defeat so far, although that loss, 3-1 to Atletico in the Madrid Derby, stung. They have the best defensive record in LaLiga, conceding seven goals in 10 games, but scoring is a concern. Girona, Atletico Madrid and Barca all have more goals than Madrid’s 21. They’ve over-relied on Jude Bellingham’s over-performance (with eight goals) and while Joselu has delivered (with five) neither Vinícius Júnior (two, after a month out through injury) or Rodrygo Goes (one) have done enough.

Editor’s Picks

2 Related

Bellingham has been LaLiga’s strongest player this season, with those eight goals coming from 22 shots and an xG (Expected Goals) of 4.05, but Rodrygo has been its most profligate, with one goal from 34 shots and an xG of 3.88.

Barcelona are the only unbeaten team in LaLiga, but their record has been marred by three unnecessary draws: 0-0 at Getafe, 2-2 at Mallorca and 2-2 at Granada. Both 2-2s were characterised by glaring defensive errors, while goalkeeper Marc-Andre ter Stegen’s decline from last season’s superhuman form to “mere mortal” has also contributed. His Goals Prevented — which subtracts the number of goals conceded from the number of goals he’d be expected to concede — is at -0.01. Basically, he’s only saving what he should, nothing more.

Five of Barca’s seven league wins have come with narrow one-goal margins, including their last two, 1-0s v Sevilla and Athletic Club. Hit hard by injuries, new arrivals Joao Felix and Joao Cancelo have been crucial as have youngsters Lamine Yamal and most recently, thanks to his match-winner against Athletic, Marc Guiu. — Alex Kirkland

Ancelotti vs. Xavi: Comparing, contrasting their coaching styles and how it might play out on Saturday

They’re eons apart in terms of age and experience, but the pair are eternally linked by the fact that both men possess the extraordinary power to convince and inspire. Okay, they also share the fact that their careers were spent in all-time great midfields — Ancelotti as more of an organiser and prompter with Roma and Milan, Xavi a wonderful orchestra-conductor with one of the best passing ranges in history. But in the modern era, an age where top coaches truly need to get under the skin and understand the psyches of their superstar players, “Carletto” and Xavi are blessed with warmth, tremendous communicative powers and a fascination for building.

To some extent, and without overdoing it, the style of football each coach promotes tells a little bit about how they were as players.

Ancelotti was talented, smart and successful: make no mistake about that. But he was pragmatic too, often charged with ensuring that the legendary players around him excelled.

Xavi, both the player and the coach, wasn’t only an evangelist for a very specific style of football — he was/is something of an “ultra.” To him, it’s We play this way, and no other way, and I’m never changing. It’s something that, given Barcelona’s awful injury problems, might cost him in this Clásico. They might need a practical approach, rather than a daring one, to compete with this version of Madrid, but he will stick to his principles.

Please note that there’s extreme respect and affection between the two; they are both what you might call “gentlemen.” Does that mean that it’s impossible that they get tense, noisy and agitated on Saturday? No, not at all. But once the dust settles, they’ll still be from an elite group: football’s good guys. — Graham Hunter

Are Barcelona’s injuries going to be too much to overcome?

When Barcelona scored the winning goal against Athletic on Sunday night, the players celebrating in the stands were bigger names than the ones celebrating down on the pitch. Frenkie de Jong, Robert Lewandowski, Raphinha, Pedri and Jules Kounde were all up there, collectively leaving a huge gap in the team down there.

Three days later, when Barcelona faced Shakhtar Donetsk in the Champions League, they did so with only 14 first-team players available. The hope remains that some of those — Lewandowski and De Jong the most likely — will be available by the time the Clasico comes around. But then, let’s go back to the start: when Barcelona scored the winning goal against Athletic on Sunday night.

That night, Marc Guiu scored the winner. Aged 17, making his first-team debut, he had been on the pitch for 33 seconds. Against Shakhtar, the outstanding performer was Fermin Lopez, another kid from the academy.

The truth is that teams tend to turn to youth when they have problems; although Barcelona is a bit different, that’s even the case there. The good news for the club is that they so often seem to respond. Made in La Masia, the phrase goes, and what’s made there is good. This is the club, of course, that filled an entire Ballon d’Or podium with homegrown players: Iniesta, Xavi and Messi.

Of course, that’s not to say that these kids are as good, or still less that Barcelona will be unconcerned if they do not get some of their top players back in time for Saturday’s kick off. Madrid, after all are a different proposition, Barcelona have struggled to get going without De Jong, Oriol Romeu especially, and Lewandowski’s presence is vital in a game like this. But if Guiu and Lopez have been goalscorers in the last two games, teenager Lamine Yamal has also been a sensation — good enough that Raphinha’s place isn’t guaranteed even when he’s fit. Alejandro Balde is now a regular.

And they do at least have one veteran leader available: 19-year-old midfielder Gavi. — Sid Lowe

Who will be the key player to tip this contest one way or the other?

Bellingham, middle, will be a clear player to watch in Saturday’s contest. Jose Manuel Alvarez/Quality Sport Images/Getty Images

Ilkay Gundogan. In terms of headlines, the Germán midfielder has made a low-key start to his Barcelona career. But with injuries to Pedri and De Jong, the responsibility in midfield has been thrust upon him, and he has plenty of big-game experience. No Barça player has created more chances (21) in LaLiga this season, and Gundogan will be tasked with finding the spaces in Madrid’s half. — Sam Marsden

The obvious answer is Bellingham, and I’m sure others will have picked him … so for variety’s sake, how about Vinicius Junior? He hasn’t hit the heights of the past two seasons, but after a month back from injury, he’s shown signs — against Napoli and Osasuna in particular — of being close to his best. Madrid’s left-hand side with Vinícius and Bellingham — the latter has been drifting left in recent games, both in and out of possession — could be decisive. They’ll love attacking the space behind Barça defender Joao Cancelo when he gets forward. — Alex Kirkland

I don’t buy the idea that there’s one key guy in a Clasico. These games often have some of Newton’s Third Law of Motion in them: in other words, for each great performance, there’s almost always an equal and opposite nightmare display. So, while it’s obvious that Bellingham’s form puts him forward as Madrid’s key man, what about Vinicius? Xavi will rely heavily on Cancelo and Ronald Araújo to shackle them. Whichever of those pairs of players dominate is where you’ll find the proverbial “key man.” On paper it’s the Englishman, but Araujo is pretty special. I’m saying Bellingham or Araujo. — Graham Hunter

LIVE ON ESPN+ (SELECTED GAMES)

The beautiful game lives here. Stream top leagues, tournaments and teams.
Sign up for ESPN+

SATURDAY, OCT. 28 (all times ET)
• Southampton vs. Birmingham City (7 a.m.)
• Schalke 04 vs. Hannover 96 (7 a.m.)
• Barcelona vs. Real Madrid (9 a.m.)
• Bayern Munich vs. Darmstadt (9 a.m.)
• Ipswich Town vs. Plymouth (10 a.m.)
• RB Leipzig vs. Köln (12 p.m.)
• NCAA: U Penn vs. Columbia (1 p.m.)
• Cadiz vs. Sevilla (3 p.m.)
• NCAA: Harvard vs. Yale (5 p.m.)
• NCAA: San Diego vs. Santa Clara (10 p.m.)

SUNDAY, OCT. 29 (all times ET)
• Club Brugge vs. Royal Antwerp (8 a.m.)
• PSV vs. Ajax (9 a.m.)
• Eintracht vs. Borussia Dortmund (9 a.m.)
• Real Betis vs. Osasuna (9 a.m.)
• Athletic Club vs. Valencia (1 p.m.)
• Atletico Madrid vs. Alavés (4 p.m.)

Fermín López. The youngster provides a lot of fight in the middle of the pitch, as well as an ability to get into the box and contribute. He could be the unexpected hero in a game full of superstars. He scored a brilliant goal against Madrid in the Clásico played in Dallas over the summer, and he’ll be extra-motivated for his first competitive meeting against Los Blancos because he’s been a Barça fan all his life. — Moises Llorens

Jude Bellingham will be the key, for various reasons. First, because he’ll be responsible for alleviating some of the pressure on Rodrygo and Vinicius to score in such an important Clasico. Second, his form would naturally intimidate any opponent and third, his strength of personality is overwhelming — where better than Montjuic to stake his claim to being the player of the season? Bellingham’s assertive play will be vital in keeping Romeu busy in the Barca midfield and free up his two Brazilian teammates, who both head into Saturday’s game with something to prove. — Rodrigo Faez

Betting picks

Odds courtesy of Caesars Sportsbook

Barcelona cruised to the LaLiga title last season, winning by 10 points over second-place Real Madrid despite underlying numbers that were much closer than that. Through 10 games this season Real Madrid are atop LaLiga, one point ahead of third-place Barcelona, though Barcelona’s underlying numbers are better so far.

However, the biggest on-field storyline for this game is injuries. Barcelona had only 12 first-team players available for Wednesday’s Champions League game, and they likely won’t have Robert Lewandowski, Frenkie de Jong or Pedri (among others) for El Clasico. Without those playmakers, it’s hard to see Barcelona piling up scoring opportunities.

Joao Felix has been quite good this season, with three goals and three assists, but Real Madrid’s defense has been solid, conceding the third-worst shots in LaLiga so far. I like Barcelona under 1.5 goals at -125.

Real Madrid obviously aren’t intimidated by playing at Camp Nou, winning three of their last four league meetings there, and five of the last seven overall. Manager Ancelotti has seen everything everywhere, and he’s won half of his league games vs Barcelona since rejoining Madrid two years ago. Given all that experience and pedigree, I’m taking Real Madrid to win and 2+ total goals, which Caesars has +225.

With Barcelona’s health issues, Real Madrid is simply better right now, and 27 of the last 30 league Clasicos have had multiple goals. — Paul Carr

Prediction time! Who will win on Saturday?

Barcelona 2-1 Real Madrid. Either I’m really bad at predictions, or recent Clásicos have defied logic. On that basis, despite a lengthy list of injuries, I’m tipping Barça to edge it. Bellingham will get his goal, but Xavi’s side will make the most of their home advantage. — Sam Marsden

Barcelona 1-3 Real Madrid. It’s a tough one to call; the teams met five times last season, with Barça winning three of them, but I’m reminded of the way Madrid hurt Barca on the break in their 4-0 Copa del Rey win at Camp Nou in April. Barça might dominate possession, but the pace of Vinicius, Rodrygo, Fede Valverde and Bellingham could do serious damage on the counterattack. — Alex Kirkland

Madrid will win. Barcelona, under Xavi, have the better Clasico record in recent months. But whichever side is in better physical condition gets a huge advantage in imposing their quality more successfully. Los Blancos have better momentum, fewer problems and that 4-0 thrashing of Barcelona at Camp Nou last time they visited (in the Copa). — Graham Hunter

Barcelona 1-1 Real Madrid. With Barça’s long injury list — it’s worth noting that even if they get some players back, they will be out of match rhythm — Madrid are favourites thanks to their strength and stability in midfield. However, Barça have home advantage, which makes a draw seems reasonable. — Moises Llorens

Barcelona 1-2 Real Madrid. Neither defence is as strong as in other seasons, given the players missing, so I think both teams will score. Taking into account the tiredness of Champions League action in midweek, both will be similar in terms of strength, but I think Madrid are a superior team physically. A game like that could go in favour of the visitors if Los Blancos are able to impose themselves early and maintain their high-scoring form. — Rodrigo Faez

Categories
Health

We had a busy week of trades in an oversold market. Here is the day-by-day breakdown

Jim Cramer on Squawk on the Street, June 30, 2022.

Virginia Sherwood | CNBC

Elevated bond yields and geopolitical uncertainty continued to be negative for stocks this week as the overall market moved into oversold territory. However, that set us up to put cash to work and make four small buys as our discipline mandates. We also upgraded one of our tech giants after it reported a stellar quarter but saw its stock punished.

Categories
Science

JWST Sees 4 Exoplanets in a Single System

When the JWST activated its penetrating infrared eyes in July 2022, it faced a massive wish-list of targets compiled by an eager international astronomy community. Distant, early galaxies, nascent planets forming in dusty disks, and the end of the Universe’s dark ages and its first light were on the list. But exoplanets were also on the list, and there were thousands of them beckoning to be studied.

But one distant solar system stood out: HR 8799, a system about 133 light-years away.

Why this system over others? 15 years ago astronomers discovered three exoplanets orbiting the star. Not long after they announced a fourth, all detected with direct imaging. They’re all massive planets on wide orbits, which are rare. The HR 8799 system is also young, another important point.

The fact that they were discovered 15 years ago is also important; it means we have observations of these planets that span a lengthy time. This type of data is critical to understanding other solar systems because the duration of the data paints a more complete picture.

However, it also poses more questions and whets our appetite for more answers.

That’s why the JWST observed the system recently. Its MIRI instrument and its coronagraph can perform the kind of high-contrast imaging needed to understand the system better.

A new paper presents the results of these observations. It’s title is “Imaging detection of the inner dust belt and the four exoplanets in the HR 8799 system with JWST’s MIRI coronagraph.” It’ll appear in the journal Astronomy and Astrophysics, and the lead author is Anthony Boccaletti from the LESIA, Observatoire de Paris, France.

HR 8799 is 1.5 times more massive than the Sun and is almost five times more luminous. It’s also surrounded by a debris disk and is only about 30 million years old. Young solar systems are important because they can reveal the intricate details behind planet formation, one of the things the JWST was built to focus on.

The four planets are HR 8799 b, c, d, and e. They’re all massive planets, between 5.7 and 9.1 Jupiter masses, barely below the point where deuterium fusion takes place, making them brown dwarfs. They range from 16 to 71 astronomical units away from the star, and have orbits from about 45 to about 460 years. All four of them have radii of about 1.2 Jupiter radii.

A portrait of the HR8799 planetary system as imaged by the Hale Telescope. A fourth planet was eventually discovered. Credit: NASA/JPL-Caltech/Palomar Observatory.

Massive giant planets that follow large orbits greater than 5 AU are rare. So every instance of these types of planets is important. MIRI’s high contrast imaging can open up a new window on these types of systems and allowing scientists to characterize them more fully. Mid-infrared observations of the system have been difficult up until now. Not only that, but the JWST’s angular resolution makes the observations even more powerful.

What did the JWST find?

“Overall, the MIRI images of the HR 8799 system yield a very different vision than in the near IR, with the clear detection of the four planets, together with a localized but extended central emission,” the authors write.

The JWST was able to refine what we already know about some aspects of this system. The main objective of this work was to characterize the planetary atmospheres better.

While there has been some uncertainty around the nature of the planets, and if they are brown dwarfs, the JWST observations put that idea to rest. “Their colors indicate that these four giant planets differ from field brown dwarfs,” the authors write.

An artist’s depiction of the relative sizes of the Sun, a low-mass star, a brown dwarf, Jupiter, and the Earth. While there was some initial uncertainty over the nature of the planets around HR 8799, the JWST images confirmed them as planets rather than brown dwarfs. Image Credit: Jupiter: NASA,ESA,and A. Simon (NASA,GSFC); Sun and Low-Mass Star: NASA,SDO; Brown Dwarf: NASA,ESA,and JPL-Caltech; Earth: NASA; Infographic: NASA and E. Wheatley (STScI)

Their temperatures range from 900 K to 1300 K, with HR 8799 b being fainter and cooler. The JWST measurement’s shows that planet b’s temperature is lower than previous observations showed, an indication of the telescope’s greater power. MIRI also identified two atmospheric chemicals unequivocally: H2O and CO. The authors say there’s a debatable detection of methane, and that’s additional evidence that they’re planets not brown dwarfs. Brown dwarfs always show the signature for methane at these temperatures.

The JWST’s MIRI instrument was built with different filters. They were partly designed to investigate the presence of ammonia, which is a solid biosignature on terrestrial planets. Unfortunately, these four planets are a little too hot for ammonia to stand out. “As a result, the current data cannot conclude on the detectability of the ammonia feature in the HR 8799 planets,” the paper states. If it had detected ammonia, it would be headline news.

This is one of the JWST’s MIRI images of HR 8799 and its four planets. It won’t grace the cover of a magazine; it’s a scientific image. Image Credit: Boccaletti et al. 2023.

The HR 8799 system is also noteworthy for its debris disk. It’s unusual in that it has two belts. Researchers have wondered if the inner edge of the outer belt was caused by a fifth planet with a mass between Jupiter’s and Saturn’s. Others thought it might be a dust clump.

But the JWST shows that it’s a background object, and seems to have ended the debate. “With a new data point, 4.44 years apart from the former detection, we can now safely conclude that this is a background
object,” the authors write.

The powerful filters on the JWST’s MIRI instrument ended the debate about a potential fifth planet at HR 8799. This MIRI image helped determine that the object is in fact a background object. Image Credit: Boccaletti et al. 2023.

This was the JWST’s first look at a young exoplanetary system with its MIRI instrument, including its filters and its coronagraph. “The MIRI instrument onboard JWST is now offering high-contrast imaging capacity at mid-IR wavelengths, thereby opening a completely new field of investigation to characterize young exoplanetary systems,” the authors explain.

As such, the main thrust of the work was to test the observations and different algorithms to determine how to best use it in future work, and how to interpret the results. For example, measuring a planet’s flux successfully means accounting for how the coronagraph attenuates the images, depending on a planet’s position.

These observations contribute to using the instrument more effectively. Ironically, MIRI’s coronagraph can be so sensitive that understanding its images of young stellar systems can be challenging. The use of the instrument is only in its infancy, and the coronagraphs extreme sensitivity “can make the detection and the interpretation of young system observations very challenging, not mentioning the confusion related to background galaxies,” the authors write.

The authors point out that there’s still room for improvement, and these results will only lead to improved future results.

Like this:

Like Loading…

Categories
Technology

Netherlands begins constructing €1.5bn hydrogen pipeline

Today, the Netherlands officially began constructing a 1,200km-long hydrogen pipeline — amid a continent-wide push to wean Europe off natural gas.

The first section of the pipeline will run from the Maasvlakte — a massive man-made extension of the Europoort in Rotterdam (Europe’s largest port) — some 30 kilometres inland to a gas refinery in Pernis, run by petrochemical giant Shell. This phase is scheduled to open in 2025 at a cost of €100mn. 

The ribbon-cutting ceremony was attended by the country’s King Willem-Alexander, the minister for climate and energy policy, Rob Jetten, and Han Fennema, CEO of state-run energy company Gasunie.

“The start of the construction of the hydrogen network today is an important milestone,” said Jetten earlier today. “Hydrogen is ideally suited to making our industry more sustainable and offers economic opportunities for the Netherlands as an important link in Northwestern Europe. I am proud that we are the first country to start building a national network.” 

The <3 of EU tech

The latest rumblings from the EU tech scene, a story from our wise ol’ founder Boris, and some questionable AI art. It’s free, every week, in your inbox. Sign up now!

From 2030, the wider 1,200km network will connect import terminals and hydrogen production facilities with major industrial clusters in the Netherlands, Germany, and Belgium. A large chunk of the network will be made up of repurposed gas pipelines, many of which are set to become redundant as the country looks to reduce its reliance on the fossil fuel. The megaproject will cost about €1.5bn.

The Dutch are building a country-wide hydrogen network that will link places of production with places of consumption, both within the country and beyond its borders. Credit: Gasunie/S&P Global Commodity Insights

The plans tie into the European Hydrogen Backbone initiative, which aims to build a network of 28,000km of dedicated hydrogen pipelines by 2030, expanding to 53,000km across 28 European countries by 2040. The initiative is backed by a group of 31 energy infrastructure operators.

In 2022, hydrogen accounted for less than 2% of Europe’s energy consumption and was primarily used to produce chemical products, such as plastics and fertilisers. Some 96% of this hydrogen was produced with natural gas, resulting in significant amounts of CO2 emissions. 

However, hydrogen — especially the ‘green’ variety produced by the electrolysis of water powered by renewable energy — has been identified by the EU as a key component of the bloc’s future energy mix. The Union plans to produce and import a total of 20 million tonnes of renewable hydrogen a year by 2030. (For context, one kilogram of hydrogen is the energy equivalent of one gallon (3.78 litres) of petrol). Proponents say this will help replace natural gas, powering vehicles and generating electricity.   

You see, some sectors like heavy industry and transportation are almost impossible to decarbonise by electrification alone — they require an easily transferable fuel. And hydrogen, which can be used in existing natural gas networks and emits only water vapour when combusted, is the perfect candidate.

While the Netherlands and many others are furiously building new infrastructure to transport the fuel, their efforts will be futile unless the production of green hydrogen is scaled up in parallel. Currently, green hydrogen accounts for only about 1% of global hydrogen production. It is also about three times as expensive as its grey counterpart, produced from fossil fuel sources. 

One solution showing great promise is wind-to-hydrogen technology, which harnesses the power of offshore wind and vast quantities of water (aka the ocean) to produce fossil-free hydrogen. The first plant of this type was opened in September off the coast of Le Croisic, France. Today it produces half a tonne of hydrogen per day. Only a fraction of what’s needed, but a notable start.  

Categories
Entertainment

Al Pacino & Noor Alfallah Agree On Custody Phrases For Toddler Son

Al Pacino, 83, and the mother of his infant son, Roman, have settled their custody agreement. Noor Alfallah, 29, first filed for full physical custody of the four-month-old early last month.

RELATED: Al Pacino Is Expecting A Baby With His 29-Year-Old Girlfriend

According to court documents reviewed by Entertainment Tonight, the couple agreed on Roman’s custody, visitation schedules, and child support. However, the finalized details about each subtopic remain undisclosed.

Al Pacino’s GF Has Not Revealed Why She Filed The Custody Agreement

It’s also unclear if Al Pacino and Noor live together, despite his publicist,  Stan Rosenfield, confirming they’re still in a relationship. Rosenfield spoke to ET about the development last month.

He stated that it’s unclear why Noor filed for custody, saying, “That is a question for Noor.”

“Al and Noor have successfully worked together and have mutually reached agreements regarding their child Roman,” the publicist said. “They are together.”

As for the coins Noor spent on filing the custody agreement, Pacino has agreed to pay her attorneys’ fees — one of Noor’s requests in the initial filing.

In the paperwork, Alfallah sought to “determine parental relationship” with Al — a practice typically used by “unmarried couples,” per Page Six. Even though she asked for full physical custody, the 29-year-old sought to share legal custody of Roman. Noor also elected to allow the “Scarface” actor to have a say in their child’s “education, medical treatment, and religion.” 

According to ET, Al Pacino and Noor’s romance drew public interest in April 2022. At the time, paparazzi photographed the pair exiting an Italian restaurant in Venice, California, and leaving in the same car. However, the outlet added that the evening involved a group of friends, including actor Jason Momoa.

We learned that Noor was expecting her first child with Pacino in May while she was eight months pregnant. The actor is also a father to three adult children, Julie Pacino and twins Olivia and Anton Pacino.

Before Noor filed in September, they were photographed arriving at a Bad Bunny music video shoot on Aug. 24, per Getty Images. 

NEW YORK, NEW YORK – AUGUST 24: Noor Alfallah and Al Pacino arrive for a music video shoot with Bad Bunny on August 24, 2023, in New York City. (Photo by Gotham/GC Images)

 

RELATED: Hey Papi! Maluma Reveals He’s Expecting A Daughter With Girlfriend Susana Gomez
Categories
Health

Bristol Myers Squibb (BMY) Q3 earnings report 2023

Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition. 

Bristol Myers, one of the world’s largest pharmaceutical companies, raked in $10.96 billion in revenue for the third quarter, down 2% from the same period last year. 

The drugmaker said that decline was due to lower sales of Revlimid, which generated $1.43 billion for the quarter. Bristol Myers has been under pressure to launch or acquire new drug products as Revlimid – and eventually, other top-selling treatments such as blood thinner Eliquis and cancer immunotherapy Opdivo – competes with cheaper generic versions. 

Revlimid sales, which fell 41% from the third quarter of 2022, also dropped due to an increase in patients receiving the drug at no cost through the company’s patient assistance foundation, Bristol Myers said. 

Bristol Myers’ existing drugs and the potential for new drug launches give the company confidence in its ability to navigate Revlimid’s patent expiration through 2025, outgoing CEO Giovanni Caforio said during an earnings call.

The company reported net income of $1.93 billion, or 93 cents per share. That compares with a net income of $1.61 billion, or 75 cents per share, for the year-ago period. Excluding certain items, adjusted earnings per share were $2 for the period.

Here’s what Bristol Myers Squibb reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv:

  • Earnings per share: $2 adjusted vs. $1.76 expected
  • Revenue: $10.96 billion vs. $10.96 billion expected

Shares of Bristol Myers closed more than 6% lower Thursday and hit a new 52-week low. The stock is down more than 26% for the year, putting the company’s market value at roughly $110 billion. 

Bristol Myers narrowed its full-year adjusted earnings outlook to $7.50 to $7.65 per share, from a previous forecast of $7.35 to $7.65 a share. Bristol Myers also reiterated its full-year revenue guidance of a low single-digit percentage decline. 

Notably, the company hiked its full-year revenue projection for Revlimid to $6 billion from $5.5 billion in July, even as the drug sees falling sales. Bristol Myers also said it expects its new drug portfolio to rake in about $3.5 billion this year.

However, the company pushed back its timeframe for its new drugs to hit $10 billion in sales to 2026, incoming CEO Christopher Boerner said during the earnings call. The drugmaker had previously forecast $10 billion to $13 billion of sales for the portfolio in 2025.

Bristol Myers said both older and new drug products helped offset the lower sales of Revlimid for the third quarter.

More CNBC health coverage

Eliquis raked in $2.71 billion in sales for the quarter and Opdivo generated $2.28 billion, up 2% and 11% from the year-ago period, respectively. However, both drugs fell short of analyst estimates compiled by FactSet. 

Eliquis, which Bristol Myers shares with Pfizer, is among the first 10 drugs selected to face price negotiations with the federal Medicare program. 

Meanwhile, a portfolio of several newer products booked $928 million in sales for the quarter, up 68% from the year-ago period. Bristol Myers said that growth was primarily driven by higher demand, including for prescription anemia medication Reblozyl, which generated $248 million in sales for the quarter. 

Skin cancer drug Opdualag also raked in $166 million in sales for the third quarter, which is up 98% from the same quarter a year ago. Those two drugs missed analyst sales estimates compiled by FactSet. 

Don’t miss these CNBC PRO stories: